Home Cart 0 Sign in  
X

[ CAS No. 17102-63-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 17102-63-5
Chemical Structure| 17102-63-5
Chemical Structure| 17102-63-5
Structure of 17102-63-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 17102-63-5 ]

Related Doc. of [ 17102-63-5 ]

Alternatived Products of [ 17102-63-5 ]

Product Details of [ 17102-63-5 ]

CAS No. :17102-63-5 MDL No. :MFCD07369762
Formula : C8H9BrO2 Boiling Point : -
Linear Structure Formula :- InChI Key :HBEIHPSICGGZIF-UHFFFAOYSA-N
M.W : 217.06 Pubchem ID :15128243
Synonyms :

Calculated chemistry of [ 17102-63-5 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.25
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 46.76
TPSA : 29.46 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.42 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.28
Log Po/w (XLOGP3) : 1.7
Log Po/w (WLOGP) : 1.8
Log Po/w (MLOGP) : 1.95
Log Po/w (SILICOS-IT) : 2.34
Consensus Log Po/w : 2.01

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.53
Solubility : 0.643 mg/ml ; 0.00296 mol/l
Class : Soluble
Log S (Ali) : -1.93
Solubility : 2.53 mg/ml ; 0.0116 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.21
Solubility : 0.133 mg/ml ; 0.000611 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.42

Safety of [ 17102-63-5 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 17102-63-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 17102-63-5 ]
  • Downstream synthetic route of [ 17102-63-5 ]

[ 17102-63-5 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 139102-34-4 ]
  • [ 17102-63-5 ]
YieldReaction ConditionsOperation in experiment
94% With lithium borohydride In tetrahydrofuran at 60℃; for 16 h; Inert atmosphere To a solution of methyl 4-bromo-2-methoxybenzoate (7.14g, 29mmol) in THF (35mL) was added a 2M solution of LiBH4 in THF (35mL, 70mmol, 2.4equiv). The solution was heated at 60°C for 16h. The reaction was then cooled to room temperature, and the solvent was removed under vacuum. The residue was stirred in a 5percent aqueous acetic acid solution (pH 6) for 15min. The aqueous layer was extracted with EtOAc (2×50mL), then the combined organic extracts were washed with brine, dried (MgSO4), filtered, and concentrated to yield the crude product as a tan oil. The oil was purified by flash chromatography using 5percent EtOAc in hexanes to provide 5.96g (94percent) of the product as a white solid: Rf 0.30 (10percent EtOAc/hexane); 1H NMR (CDCl3) δ 7.30 (d, 1H), 7.14 (d, 1H), 7.11 (s, 1H), 5.09 (t, 1H), 4.42 (d, 2H,), 3.77 (s, 3H).
Reference: [1] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 1, p. 419 - 434
[2] Journal of Medicinal Chemistry, 1992, vol. 35, # 4, p. 734 - 740
[3] Patent: WO2006/60461, 2006, A1, . Location in patent: Page/Page column 197
[4] ChemMedChem, 2010, vol. 5, # 1, p. 65 - 78
[5] Patent: WO2012/66335, 2012, A1, . Location in patent: Page/Page column 54
  • 2
  • [ 43192-33-2 ]
  • [ 17102-63-5 ]
Reference: [1] Molecules, 2013, vol. 18, # 4, p. 3872 - 3893
  • 3
  • [ 17102-63-5 ]
  • [ 43192-33-2 ]
YieldReaction ConditionsOperation in experiment
71%
Stage #1: With oxalyl dichloride; dimethyl sulfoxide In dichloromethane at -78℃; for 0.5 h; Inert atmosphere
Stage #2: With triethylamine In dichloromethane at -78 - 20℃; for 16 h; Inert atmosphere
A solution of anhydrous DMSO (5.1mL, 73mmol, 3.0equiv) in anhydrous dichloromethane (50mL) was cooled to −78°C in a dry ice/i-PrOH bath. Oxalyl chloride (6.4mL, 73mmol, 3.0equiv) was added dropwise over 45min. The mixture was stirred for 15min and a solution of 4-bromo-2-methoxybenzyl alcohol (30b; 5.30g, 24mmol) in dichloromethane (10mL) was added dropwise. The resulting mixture was stirred for 30min at −78°C. Triethylamine (12.4g, 120mmol, 5.0equiv) was then added, and the mixture was allowed to warm to rt over 16h. The mixture was quenched with water (100mL) and extracted with chloroform (3×200mL). The combined organic extracts were washed with water (1×150mL), brine (1×150mL), dried (MgSO4), filtered, and evaporated to yield the crude product as dark residue. The residue was purified by flash chromatography using chloroform to obtain an off-white solid that was recrystallized from hexanes to yield 3.73g (71percent) of the product as a white solid: Rf 0.18 (5percent EtOAc/hexane); mp 65–67°C; 1H NMR (CDCl3) δ 10.39 (s, 1H), 7.68 (d, 1H), 7.2–7.16 (m, 2H), 3.94 (s, 3H).
Reference: [1] Journal of Materials Chemistry, 2011, vol. 21, # 26, p. 9523 - 9531
[2] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 1, p. 419 - 434
[3] Journal of Medicinal Chemistry, 1992, vol. 35, # 4, p. 734 - 740
[4] ChemMedChem, 2010, vol. 5, # 1, p. 65 - 78
[5] Angewandte Chemie - International Edition, 2013, vol. 52, # 39, p. 10295 - 10299[6] Angew. Chem., 2013,
[7] Organic Letters, 2014, vol. 16, # 9, p. 2318 - 2321
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 17102-63-5 ]

Aryls

Chemical Structure| 14804-31-0

[ 14804-31-0 ]

4-Bromo-1-methoxy-2-methylbenzene

Similarity: 0.93

Chemical Structure| 170434-11-4

[ 170434-11-4 ]

5-Bromo-2-(hydroxymethyl)phenol

Similarity: 0.90

Chemical Structure| 6793-92-6

[ 6793-92-6 ]

1-Bromo-4-(phenylmethoxy)benzene

Similarity: 0.89

Chemical Structure| 14804-38-7

[ 14804-38-7 ]

4-Bromo-2,6-dimethylanisole

Similarity: 0.89

Chemical Structure| 29578-83-4

[ 29578-83-4 ]

1-Bromo-3-methoxy-5-methylbenzene

Similarity: 0.89

Bromides

Chemical Structure| 14804-31-0

[ 14804-31-0 ]

4-Bromo-1-methoxy-2-methylbenzene

Similarity: 0.93

Chemical Structure| 170434-11-4

[ 170434-11-4 ]

5-Bromo-2-(hydroxymethyl)phenol

Similarity: 0.90

Chemical Structure| 6793-92-6

[ 6793-92-6 ]

1-Bromo-4-(phenylmethoxy)benzene

Similarity: 0.89

Chemical Structure| 14804-38-7

[ 14804-38-7 ]

4-Bromo-2,6-dimethylanisole

Similarity: 0.89

Chemical Structure| 29578-83-4

[ 29578-83-4 ]

1-Bromo-3-methoxy-5-methylbenzene

Similarity: 0.89

Ethers

Chemical Structure| 14804-31-0

[ 14804-31-0 ]

4-Bromo-1-methoxy-2-methylbenzene

Similarity: 0.93

Chemical Structure| 6793-92-6

[ 6793-92-6 ]

1-Bromo-4-(phenylmethoxy)benzene

Similarity: 0.89

Chemical Structure| 14804-38-7

[ 14804-38-7 ]

4-Bromo-2,6-dimethylanisole

Similarity: 0.89

Chemical Structure| 36942-56-0

[ 36942-56-0 ]

2-Bromo-4-methoxy-1-methylbenzene

Similarity: 0.89

Chemical Structure| 29578-83-4

[ 29578-83-4 ]

1-Bromo-3-methoxy-5-methylbenzene

Similarity: 0.89

Alcohols

Chemical Structure| 170434-11-4

[ 170434-11-4 ]

5-Bromo-2-(hydroxymethyl)phenol

Similarity: 0.90

Chemical Structure| 2316-64-5

[ 2316-64-5 ]

4-Bromo-2-(hydroxymethyl)phenol

Similarity: 0.88

Chemical Structure| 150192-39-5

[ 150192-39-5 ]

(2-Bromo-5-methoxyphenyl)methanol

Similarity: 0.87

Chemical Structure| 17100-64-0

[ 17100-64-0 ]

(4-Bromo-3-methoxyphenyl)methanol

Similarity: 0.87

Chemical Structure| 38493-59-3

[ 38493-59-3 ]

(3-Bromo-4-methoxyphenyl)methanol

Similarity: 0.87